Compare RWT & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RWT | CDNA |
|---|---|---|
| Founded | 1994 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 693.0M | 712.2M |
| IPO Year | 1995 | 2014 |
| Metric | RWT | CDNA |
|---|---|---|
| Price | $5.62 | $20.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $7.00 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 1.1M | 816.3K |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | ★ 12.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.22 |
| Revenue | $120,897,000.00 | ★ $357,998,000.00 |
| Revenue This Year | N/A | $14.11 |
| Revenue Next Year | $46.22 | $12.00 |
| P/E Ratio | ★ N/A | $16.92 |
| Revenue Growth | N/A | ★ 14.46 |
| 52 Week Low | $4.68 | $10.96 |
| 52 Week High | $7.19 | $25.95 |
| Indicator | RWT | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 58.59 | 71.98 |
| Support Level | $5.45 | $18.36 |
| Resistance Level | $5.70 | $19.95 |
| Average True Range (ATR) | 0.13 | 0.86 |
| MACD | 0.03 | 0.19 |
| Stochastic Oscillator | 86.72 | 99.42 |
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.